PEP-Therapy
PrivateLast Round
Series A
Extension
Jul 19, 2021
Total Funding Raised
$11.27M
Company Overview
PEP-Therapy is a biotechnology company that develops first-in-class peptide-based targeted therapies for oncology using an intracellular drug delivery shuttle.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologypeptide therapytargeted oncologydrug delivery platformintracellular deliverysolid tumorsdrug discoveryprecision medicineclinical trialsbiotech startuptherapeutic peptidesundruggable targetsprotein phosphatase 2APP2Adrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PEP-Therapy Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
PEP-Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 19, 2021 | ||||
| Series A | Apr 22, 2021 | ||||
| Grant | Apr 17, 2018 | ||||
| Seed | Apr 27, 2015 |
PEP-Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anaxago | Series A Extension |
| Bpifrance | Series A Extension |
| Business Angels des Grandes Ecoles | Series A Extension, Series A |
| Seventure Partners | Series A |
| i&i Prague | Series A Extension |
| Doorway | Series A |
| Italian Angels for Growth | Series A |
PEP-Therapy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PEP-Therapy's valuation, stock price, and market status.
Firmographic Details
HeadquartersParis
Employee Range12
Year Founded2014
Last FundingJul 19, 2021